Home・Stock List・Bio-Techne Corp

Bio-Techne Corp

Closed

SectorHealthcare

72.79 0.17

Buy Sell

Overview

Share price change

24h

Current

Min

72.75

Max

72.79

Key metrics
By Trading Economics
Income	3.6M 55M
Sales	9.8M 321M
P/E Sector Avg	62.647 51.78
EPS	0.49
Dividend yield	0.44
Profit margin	17.006
Employees	3,000
EBITDA	-6.7M 92M

Recommendations
By TipRanks
Recommendations	Sell
12 Months Forecast	+0.3% upside

Dividends
By Acuity
Dividend yield Sector Avg	0.44% 1.96%
Next Earnings	11 Nov 2026
Next Dividend date	23 Nov 2026
Next Ex Dividend date	13 Nov 2026

Market Stats
By TradingEconomics
Market Cap	176M 11B
Previous open	72.62
Previous close	72.79

Bio-Techne Corp Chart

Past performance is not a reliable indicator of future results.

Related News

3 Nov 2026, 20:16 UTC

Bio-Techne Corporation is trading little changed, positioned near the upper end of its one-month range, despite a slight decline from earlier gains.

2 Nov 2026, 22:11 UTC

Bio-Techne Corporation is trading higher in after-market hours, supported by positive economic indicators, including an ISM Manufacturing PMI rise to 55.5 for October.

22 Oct 2026, 20:07 UTC

Bio-Techne Corp's shares are roughly flat, maintaining a position near the upper end of their one-month trading range amid minor fluctuations.

8 Sept 2026, 19:47 UTC

Correlated Moves

Bio-Techne Corp shares are lower today, reflecting a decline since Friday. Agilent Technologies' drop may be influencing Bio-Techne's performance amid inflation data focus.

28 Aug 2026, 19:46 UTC

Correlated Moves

Bio-Techne Corp is trading lower today, reflecting a broader decline in the biotech sector, including Charles River Laboratories International Inc.

27 Aug 2026, 23:31 UTC

Bio-Techne Corp shares are higher in after-market hours, though no specific news was identified. Recent economic data showed a decline in initial jobless claims.

19 Aug 2026, 19:27 UTC

Correlated Moves

Shares modestly higher, influenced by rise in iShares Biotechnology ETF.

18 Aug 2026, 21:41 UTC

Bio-Techne Corp shares are higher in after-market trading, peaking early in the session and remaining near the upper end of their one-month trading range.

17 Aug 2026, 19:16 UTC

Correlated Moves

Bio-Techne Corp is trading roughly flat amid broader market sentiment, with the Russell 2000 Index declining. Recent economic data has contributed to cautious conditions.

13 Aug 2026, 19:16 UTC

Correlated Moves

News

Bio-Techne Corp corrected its dividend record date to August 24, 2026. Shares are trading roughly flat amid broader market dynamics.

5 Aug 2026, 19:16 UTC

Correlated Moves

Bio-Techne Corp's shares are lower today, reflecting declines in the Russell 2000 Index. The stock remains near the upper end of its one-month trading range.

4 Aug 2026, 22:02 UTC

Correlated Moves

Bio-Techne Corp shares are higher in after-market trading, buoyed by positive sentiment from U.S.-Iran negotiations and gains in major technology stocks.

3 Aug 2026, 19:26 UTC

Correlated Moves

Bio-Techne Corp is advancing, reflecting broader market positivity amid gains in major tech stocks and falling energy prices. The stock is near its one-month trading range high.

31 Jul 2026, 22:02 UTC

Correlated Moves

Bio-Techne Corp shares are lower in after-market trading amid a broader market downturn, reflecting negative sentiment impacting price action.

30 Jul 2026, 18:26 UTC

Correlated Moves

Bio-Techne Corp is trading roughly flat as the broader market recovers from declines, influenced by rising Treasury yields and inflation concerns.

29 Jul 2026, 22:03 UTC

Bio-Techne Corp shares are lower in after-market hours, reflecting a decline since Wednesday's close amid cautious market sentiment and geopolitical tensions.

20 Jul 2026, 18:01 UTC

Bio-Techne Corp shares are lower today, with no specific news identified. Broader market pressures include rising yields and inflation concerns linked to oil prices.

Peer Comparison

Price change

Bio-Techne Corp Forecast

Price Target

By TipRanks

0.3% upside

12 Months Forecast

Average 73 USD 0.3%

High 73 USD

Low 73 USD

Based on 3 Wall Street analysts offering 12 month price targets forBio-Techne Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Bio-Techne Corp - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.